Citation: Rj. Molot et al., THE CLINICAL RELEVANCE OF L26, A B-CELL-SPECIFIC ANTIBODY, IN HODGKINS-DISEASE, American journal of clinical oncology, 17(3), 1994, pp. 185-188
Authors:
MENDENHALL NP
CANTOR AB
BARRE DM
LYNCH JW
MILLION RR
Citation: Np. Mendenhall et al., THE ROLE OF PROGNOSTIC FACTORS IN TREATMENT SELECTION FOR EARLY-STAGEHODGKINS-DISEASE, American journal of clinical oncology, 17(3), 1994, pp. 189-195